BCL6 inhibitor 7
CAS No. 2097518-46-0
BCL6 inhibitor 7 ( BCL6-IN-7; BCL6 IN 7; BCL6IN7; BCL6 inhibitor-7 )
Catalog No. M13307 CAS No. 2097518-46-0
A potent BCL6 protein-protein interaction inhibitor with Kd of 78 nM; exhibits an efficacy in cell-free and cellular PPI assays.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 710 | Get Quote |
|
100MG | 1116 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBCL6 inhibitor 7
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent BCL6 protein-protein interaction inhibitor with Kd of 78 nM; exhibits an efficacy in cell-free and cellular PPI assays.
-
DescriptionA potent BCL6 protein-protein interaction inhibitor with Kd of 78 nM; exhibits an efficacy in cell-free and cellular PPI assays (ELISA IC50= 480 nM, M2H IC50= 8.6 uM).
-
SynonymsBCL6-IN-7; BCL6 IN 7; BCL6IN7; BCL6 inhibitor-7
-
PathwayAngiogenesis
-
TargetBcl-2
-
RecptorBcl-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2097518-46-0
-
Formula Weight366.81
-
Molecular FormulaC18H15ClN6O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1NC2=C(C=C(NC3=NC(NCC4=CC=CN=C4)=NC=C3Cl)C=C2)C1
-
Chemical Name5-((5-Chloro-2-((pyridin-3-ylmethyl)amino)pyrimidin-4-yl)-amino)-1,3-dihydro-2H-indol-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kamada Y, et al. J Med Chem. 2017 May 25;60(10):4358-4368.
molnova catalog
related products
-
Desmorpholinyl Navit...
Desmorpholinyl Navitoclax-NH-Me is a Bcl-xL inhibitor. Desmorpholinyl Navitoclax-NH-Me and a CRBN ligand for the E3 ubiquitin ligase can be used in the synthesis of PROTAC BCL-XL degrader XZ739 .
-
17-Hydroxy sprengeri...
17-Hydroxy sprengerinin C is a glycoside compound isolated from rhizomes of Polygonatum sibiricum with stronger anticancer activities.
-
Dehydrocavidine
Dehydrocavidine has antitumor activity, it inhibits MCF-7 cell proliferation by inducing apoptosis mediated by regulating Bax/Bcl-2, activating caspases as well as cleaving PARP.